Trial Profile
Open-label, randomized multicenter phase II clinical trial of a toll-like receptor-2 agonist mycobacterium w (Cadi-05) in combination with paclitaxel plus cisplatin versus paclitaxel plus cisplatin in advanced non-small cell lung cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Jul 2011
Price :
$35
*
At a glance
- Drugs Cadi 05 (Primary) ; Cisplatin; Paclitaxel
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Sponsors Cadila Pharmaceuticals
- 30 Jun 2011 New trial record
- 07 Jun 2011 Results presented at the 47th Annual Meeting of the American Society of Clinical Oncology.